Future of prostate imaging: Artificial intelligence in assessing prostatic magnetic resonance imaging

Table 1 Current artificial intelligence products available in the prostate imaging field

Vendor	Product name	FDA approval class	CE approval class	Main features in prostate imaging
Siemens Healthineers	AI-Rad Companion Prostate MR	II	IIb - MDR	Segmentation, volume assessment, lesion annotation, PSA density
Quantib	Quantib® Prostate	II	IIb - MDR	Volume assessment, PSA density, segmentation, PI-RADS scoring, report structure
Quibim	QP-Prostate	II	IIb - MDR	ADC, Ktrans, parametric maps obtainment, volume assessment, segmentation, report structure
Quibim	Perfusion pharmacokinetics modeling	N/A	IIa - MDD	Ktrans map, volume assessment, contrast enhancement assistance
Quibim	Texture analysis	N/A	IIa - MDD	Quantification, radiomics, imaging biomarker discovery
Quibim	T2 mapping (relaxometry)	N/A	IIa - MDD	T2 values, T2 histogram
Siemens Healthineers	Prostate MR on syngo.via	N/A	IIa - MDD	Segmentation, volume assessment, lesion assessment, PI-RADS scoring
JLK Inc.	JPC-01K	N/A	I - MDD	Lesion detection
Lucida Medical	Prostate Intelligence™	N/A	I - MDD	Segmentation, lesion characterization, PI-RADS scoring, report structure
Quibim	DWI - ADC	N/A	IIa - MDD	Volume assessment, ADC support, histogram
Quibim	DWI - IVIM	N/A	IIa - MDD	ADC support, multiparametric maps, perfusion assessment

ADC: Apparent diffusion coefficient; AI: Artificial intelligence; CE: Single Market in the European economic area; DWI: Diffusion weighted imaging; FDA: Food and Drug Administration; IVIM: Intravoxel incoherent motion; JPC-01K: An artificial intelligence-based prostate cancer detection solution; K^trans: Volume transfer constant; MDD: Medical Devices Directive; MDR: Medical device regulation; MR: Magnetic resonance; N/A: Not applicable; PI-RADS: Prostate Imaging-Reporting & Data System; PSA: Prostate-specific antigen.